UDP-3-O-(R-3-hydroxymyristoyl)-N-Acetylglucosamine Deacetylase (LpxC) Inhibitors: A New Class of Antibacterial Agents

E-ISSN： 1875-533x|19|13|2038-2050

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.13, 2012-05, pp. : 2038-2050

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 4, 2018-01 ,pp. : 310-323

Bentham Science Publishers

Access to resources Recommend Favorite

Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as Histone Deacetylase Inhibitors and Antitumor Agents

Medicinal Chemistry, Vol. 11, Iss. 8, 2015-10 ,pp. : 725-735

Bentham Science Publishers

Access to resources Recommend Favorite

Bacterial Peptide Deformylase Inhibitors: A New Class of Antibacterial Agents

Current Medicinal Chemistry, Vol. 12, Iss. 14, 2005-07 ,pp. : 1607-1621

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism and Inhibition of LpxC: An Essential Zinc-Dependent Deacetylase of Bacterial Lipid A Synthesis

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 1, 2008-02 ,pp. : 9-15

Bentham Science Publishers

Access to resources Recommend Favorite

From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents

Current Pharmaceutical Design, Vol. 14, Iss. 6, 2008-02 ,pp. : 545-561

Bentham Science Publishers

Access to resources Recommend Favorite